Proteins to punch holes in cancer cells to kill them: Study

In a medical breakthrough scientists have found a protein called perforin that kills rogue cells in the human body especially the ones causing cancer. The team comprising of experts from Melbourne and London found that perforin punches holes and kills these cells. The research appeared in the acclaimed journal Nature.

Monash University professor James Whisstock explained, “Perforin is our body's weapon of cleansing and death… It breaks into cells that have been hijacked by viruses or turned into cancer cells and allows toxic enzymes in, to destroy the cell from within… Without it our immune system can't destroy these cells. Now we know how it works, we can start to fine tune it to fight cancer, malaria and diabetes.”

Earliest observations that the human immune system could punch holes in target cells was seen by Nobel laureate Jules Bordet over 110 years ago. It is now that the team from Monash University and the Peter MacCallum Cancer Centre in Melbourne, and Birkbeck College in London came together in this decade long study to look at the exact molecular mechanism. The team used Australian Synchrotron and the powerful electron microscopes at Birkbeck to find the molecular structure. They found how perforin forms a hole in the cell membranes of the target cells. They also found that the perforins worked similar to toxic bacteria like anthrax, listeria and streptococcus.

According to head of cancer immunology at the Peter MacCallum Cancer Centre, Professor Joe Trapani, “The molecular structure has survived for close to two billion years, we think.” They also noted that it is this perforin that causes the body to turn against itself like in autoimmune disease conditions, such as early onset diabetes, or in tissue rejection following bone marrow transplantation.

“The first major step in understanding perforin came from the discovery that it is related to a family of bacterial toxins, including pneumolysin, which we had previously studied,” said researcher Helen Saibil of Birkbeck College London, UK. “We went on to obtain an electron microscopy map of perforin pores, and we could see some similarities to pneumolysin pores but we couldn't interpret the structure in detail.”

“This is a wonderful extension of the breakthrough work of 2007,” said Hagan Bayley of the University of Oxford, UK, referring to the discovery of the similarity between perforin and bacterial pores. “The weapons used by our immune cells and by pathogenic bacteria have a common origin, but now it seems they swing their swords in different ways,” he added.

A $1 million grant from the Wellcome Trust will aid in further research on using these proteins against cancer and other diseases.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Proteins to punch holes in cancer cells to kill them: Study. News-Medical. Retrieved on June 16, 2024 from

  • MLA

    Mandal, Ananya. "Proteins to punch holes in cancer cells to kill them: Study". News-Medical. 16 June 2024. <>.

  • Chicago

    Mandal, Ananya. "Proteins to punch holes in cancer cells to kill them: Study". News-Medical. (accessed June 16, 2024).

  • Harvard

    Mandal, Ananya. 2018. Proteins to punch holes in cancer cells to kill them: Study. News-Medical, viewed 16 June 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionary AI tool detects multiple cancers in whole-body PET/CT scans